Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF559-ZNF177 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-09 |
mRNA | ZBTB8B | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-09 |
mRNA | PTOV1 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-09 |
mRNA | DOPEY1 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-09 |
mRNA | ZNF610 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-09 |
mRNA | KIF5C | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-09 |
mRNA | ZNF136 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
mRNA | ZNF345 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
mRNA | DPYSL5 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
mRNA | RAB39A | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |